Unknown

Dataset Information

0

Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring.


ABSTRACT: GRL-02031 (1) is an HIV-1 protease (PR) inhibitor containing a novel P1' (R)-aminomethyl-2-pyrrolidinone group. Crystal structures at resolutions of 1.25-1.55 Å were analyzed for complexes of 1 with the PR containing major drug resistant mutations, PR(I47V), PR(L76V), PR(V82A), and PR(N88D). Mutations of I47V and V82A alter residues in the inhibitor-binding site, while L76V and N88D are distal mutations having no direct contact with the inhibitor. Substitution of a smaller amino acid in PR(I47V) and PR(L76V) and the altered charge of PR(N88D) are associated with significant local structural changes compared to the wild-type PR(WT), while substitution of alanine in PR(V82A) increases the size of the S1' subsite. The P1' pyrrolidinone group of 1 accommodates to these local changes by assuming two different conformations. Overall, the conformation and interactions of 1 with PR mutants resemble those of PR(WT) with similar inhibition constants in good agreement with the antiviral potency on multidrug resistant HIV-1.

SUBMITTER: Chang YC 

PROVIDER: S-EPMC3355519 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring.

Chang Yu-Chung E YC   Yu XiaXia X   Zhang Ying Y   Tie Yunfeng Y   Wang Yuan-Fang YF   Yashchuk Sofiya S   Ghosh Arun K AK   Harrison Robert W RW   Weber Irene T IT  

Journal of medicinal chemistry 20120322 7


GRL-02031 (1) is an HIV-1 protease (PR) inhibitor containing a novel P1' (R)-aminomethyl-2-pyrrolidinone group. Crystal structures at resolutions of 1.25-1.55 Å were analyzed for complexes of 1 with the PR containing major drug resistant mutations, PR(I47V), PR(L76V), PR(V82A), and PR(N88D). Mutations of I47V and V82A alter residues in the inhibitor-binding site, while L76V and N88D are distal mutations having no direct contact with the inhibitor. Substitution of a smaller amino acid in PR(I47V)  ...[more]

Similar Datasets

| S-EPMC3574189 | biostudies-literature
| S-EPMC3719844 | biostudies-literature
| S-EPMC5118983 | biostudies-literature
| S-EPMC2751596 | biostudies-literature
| S-EPMC4133278 | biostudies-literature
| S-EPMC6535520 | biostudies-literature
| S-EPMC1891396 | biostudies-literature
| S-EPMC7251940 | biostudies-literature
| S-EPMC8051016 | biostudies-literature
| S-EPMC5613016 | biostudies-literature